Matthew T. Burger - Concepedia

Concepedia

Author

Matthew T. Burger

Novartis (Switzerland)ORCID

Also Known As

Burger M, Burger, M.T., Burger, Matthew T., Frederick, M Burger, M. T. BURGER, M.T. Burger, Matthew Burger, Matthew T Burger, Matthew T. Burger

49

Publications

1.6K

Citations

18

H-Index

79

Concepts

All Affiliations

Novartis (Switzerland)Novartis (United States)Novartis Institutes for BioMedical Research Columbia University Genomics Institute of the Novartis Research Foundation

MT

About

Matthew T. Burger is an author at Novartis (Switzerland) specializing in pharmacology, medicine, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.2K
2	Natural Sciences	12	12	923
3	Engineering	5	5	135
4	Applied Physics	2	2	26
5	Health Sciences	1	1	72

Matthew T. Burger

×

25

Publications

1.6K

Citations

18

H-Index

	Year	Citations
Identification and Characterization of NVP-BKM120, an Orally Available Pan-Class I PI3-Kinase Inhibitor Sauveur-Michel Maira, Sabina Pecchi, Alan Huang, Molecular Cancer Therapeutics PharmacotherapyDifferent Selectivity ProfileChemical BiologyPharmaceutical ChemistryTumor Biology	2011	524
Identification of NVP-BKM120 as a Potent, Selective, Orally Bioavailable Class I PI3 Kinase Inhibitor for Treating Cancer Matthew T. Burger, Sabina Pecchi, Allan S. Wagman, ACS Medicinal Chemistry Letters 2,4-Bismorpholino 6-Heterocyclic PyrimidinesPi3 Kinase InhibitorOrally Bioavailable ClassGliomaPharmaceutical Chemistry	2011	248
Pan-PIM Kinase Inhibition Provides a Novel Therapy for Treating Hematologic Cancers Pablo D. García, John L. Langowski, Yingyun Wang, Clinical Cancer Research	2014	110
Enantioselective Recognition by a New Chiral Stationary Phase at the Receptor Level Francesco Gasparrini, Domenico Misiti, Claudio Villani, The Journal of Organic Chemistry	1995	84
Identification of <i>N</i>-(4-((1<i>R</i>,3<i>S</i>,5<i>S</i>)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies Matthew T. Burger, Gisele Nishiguchi, Wooseok Han, Journal of Medicinal Chemistry Hematological MalignancyMoloney Murine LeukemiaMedicinal ChemistryKinase InhibitorMedicine	2015	72
Discovery of novel 3,5-disubstituted indole derivatives as potent inhibitors of Pim-1, Pim-2, and Pim-3 protein kinases Gisele Nishiguchi, Gordana Atallah, Cornelia Bellamacina, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryNatural SciencesMedicinePim-3 Protein Kinases	2011	62
Synthetic Ionophores. Encoded Combinatorial Libraries of Cyclen-based Receptors for Cu2+ and Co2+ Matthew T. Burger, W. Clark Still The Journal of Organic Chemistry Combinatorial ChemistryEngineeringChemical AnalysisBiochemistryDonut Icon	1995	61
Structure Guided Optimization, in Vitro Activity, and in Vivo Activity of Pan-PIM Kinase Inhibitors Matthew T. Burger, Wooseok Han, Jiong Lan, ACS Medicinal Chemistry Letters Drug TargetPan-pim Kinase InhibitorsChemical BiologyTumor BiologyMedicinal Chemistry	2013	52
Design and Discovery of <i>N</i>-(2-Methyl-5′-morpholino-6′-((tetrahydro-2<i>H</i>-pyran-4-yl)oxy)-[3,3′-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers Gisele Nishiguchi, Alice Rico, Huw R. Tanner, Journal of Medicinal Chemistry Drug TargetKras Mutant TumorsKinase InhibitorsChemical BiologyPharmaceutical Chemistry	2017	44
Free Energy Calculations in Molecular Design: Predictions by Theory and Reality by Experiment with Enantioselective Podand Ionophores Matthew T. Burger, Alan Armstrong, Frank Guarnieri, Journal of the American Chemical Society EngineeringChemical AnalysisAltmetric Attention ScoreExcitation Energy TransferComputational Chemistry	1994	38

Page 1